Research Paper Volume 14, Issue 2 pp 907—922

A radiomics model predicts the response of patients with advanced gastric cancer to PD-1 inhibitor treatment


Figure 5. Evaluation of the performance of the radiomics model. The operating characteristic curve analysis of the clinical and radiomics models was plotted in the training set (A) and in the validation set (B). The AUCs of the radiomics model were 0.865 (95% CI: 0.812-0.828) and 0.778 (95% CI: 0.732–0.776) in the training and validation datasets. While the AUCs of the clinical model were 0.750 (95% CI: 0.718–0.734) and 0.667 (95% CI: 0.665–0.724), respectively.